| HIF-1α is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of Tregs in glioblastoma J Miska, C Lee-Chang, A Rashidi, ME Muroski, AL Chang, ... Cell Reports 27 (1), 226-237. e4, 2019 | 237 | 2019 |
| Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation LK Billingham, JS Stoolman, K Vasan, AE Rodriguez, TA Poor, M Szibor, ... Nature immunology 23 (5), 692-704, 2022 | 126 | 2022 |
| Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma P Zhang, J Miska, C Lee-Chang, A Rashidi, WK Panek, S An, M Zannikou, ... Proceedings of the National Academy of Sciences 116 (47), 23714-23723, 2019 | 116 | 2019 |
| Myeloid-derived suppressive cells promote B cell–mediated immunosuppression via transfer of PD-L1 in glioblastoma C Lee-Chang, A Rashidi, J Miska, P Zhang, KC Pituch, D Hou, T Xiao, ... Cancer immunology research 7 (12), 1928-1943, 2019 | 105 | 2019 |
| Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment C Wu, ME Muroski, J Miska, C Lee-Chang, Y Shen, A Rashidi, P Zhang, ... Nanomedicine: Nanotechnology, Biology and Medicine 16, 126-137, 2019 | 54 | 2019 |
| Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma J Miska, A Rashidi, C Lee-Chang, P Gao, A Lopez-Rosas, P Zhang, ... Science Advances 7 (8), eabc8929, 2021 | 50 | 2021 |
| STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma P Zhang, A Rashidi, J Zhao, C Silvers, H Wang, B Castro, A Ellingwood, ... Nature communications 14 (1), 1610, 2023 | 46 | 2023 |
| Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma C Lee-Chang, J Miska, D Hou, A Rashidi, P Zhang, RA Burga, ... Journal of Experimental Medicine 218 (1), e20200913, 2020 | 46 | 2020 |
| Anti-GITR therapy promotes immunity against malignant glioma in a murine model J Miska, A Rashidi, AL Chang, ME Muroski, Y Han, L Zhang, MS Lesniak Cancer Immunology, Immunotherapy 65, 1555-1567, 2016 | 42 | 2016 |
| Landscape of combination therapy trials in breast cancer brain metastasis J Fares, D Kanojia, A Rashidi, I Ulasov, MS Lesniak International journal of cancer 147 (7), 1939-1952, 2020 | 37 | 2020 |
| Genes that mediate metastasis across the blood–brain barrier J Fares, D Kanojia, A Rashidi, I Ulasov, MS Lesniak Trends in cancer 6 (8), 660-676, 2020 | 36 | 2020 |
| GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma A Rashidi, J Miska, C Lee-Chang, D Kanojia, WK Panek, A Lopez-Rosas, ... Cancer Immunology, Immunotherapy 69, 81-94, 2020 | 34 | 2020 |
| Diagnostic clinical trials in breast cancer brain metastases: barriers and innovations J Fares, D Kanojia, A Rashidi, AU Ahmed, IV Balyasnikova, MS Lesniak Clinical breast cancer 19 (6), 383-391, 2019 | 28 | 2019 |
| Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma WK Panek, JR Kane, JS Young, A Rashidi, JW Kim, D Kanojia, ... Oncotarget 8 (51), 89391, 2017 | 26 | 2017 |
| Fatty acid uptake in T cell subsets using a quantum dot fatty acid conjugate ME Muroski, J Miska, AL Chang, P Zhang, A Rashidi, H Moore, ... Scientific reports 7 (1), 5790, 2017 | 26 | 2017 |
| Current state of clinical trials in breast cancer brain metastases J Fares, D Kanojia, A Cordero, A Rashidi, J Miska, CW Schwartz, ... Neuro-oncology practice 6 (5), 392-401, 2019 | 22 | 2019 |
| Local application of autologous platelet-rich fibrin patch (PRF-P) suppresses regulatory T cell recruitment in a murine glioma model WK Panek, KC Pituch, J Miska, JW Kim, A Rashidi, D Kanojia, ... Molecular neurobiology 56, 5032-5040, 2019 | 22 | 2019 |
| A dendritic cell-targeted adenoviral vector facilitates adaptive immune response against human glioma antigen (CMV-IE) and prolongs survival in a human glioma tumor model JW Kim, JR Kane, WK Panek, JS Young, A Rashidi, D Yu, D Kanojia, ... Neurotherapeutics 15 (4), 1127-1138, 2018 | 22 | 2018 |
| A comparative study of replication-incompetent and-competent adenoviral therapy-mediated immune response in a murine glioma model JW Kim, J Miska, JS Young, A Rashidi, JR Kane, WK Panek, D Kanojia, ... Molecular Therapy-Oncolytics 5, 97-104, 2017 | 18 | 2017 |
| Repurposing autophagy regulators in brain tumors E Petrosyan, J Fares, A Cordero, A Rashidi, VA Arrieta, D Kanojia, ... International journal of cancer 151 (2), 167-180, 2022 | 12 | 2022 |
Jason MiskaNorthwestern UniversityDirección de correo verificada de northwestern.edu
